Cargando…
Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
The recognition that colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behaviour and response to therapy translates into an urgent need for robust molecular disease subclassifiers that can explain this heterogeneity beyond current parameters (MSI, KRAS, BRAF). Attempts to fill...
Autores principales: | Budinska, Eva, Popovici, Vlad, Tejpar, Sabine, D'Ario, Giovanni, Lapique, Nicolas, Sikora, Katarzyna Otylia, Di Narzo, Antonio Fabio, Yan, Pu, Hodgson, John Graeme, Weinrich, Scott, Bosman, Fred, Roth, Arnaud, Delorenzi, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840702/ https://www.ncbi.nlm.nih.gov/pubmed/23836465 http://dx.doi.org/10.1002/path.4212 |
Ejemplares similares
-
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
por: Popovici, Vlad, et al.
Publicado: (2013) -
A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
por: Xie, Tao, et al.
Publicado: (2012) -
Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data
por: Buhl, Ida Kappel, et al.
Publicado: (2016) -
An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial
por: Stenvang, Jan, et al.
Publicado: (2020) -
A critical comparison of topology-based pathway analysis methods
por: Ihnatova, Ivana, et al.
Publicado: (2018)